Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Explore various ways to earn quick money through business ventures. Start your journey toward financial success right now!
26,029 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
A retiree with $1 million eyeing Florida’s Gulf Coast weighs the no state income tax boost against housing costs, ins...
Ready to make rental properties a real pathway to retirement? This guide outlines three actionable strategies for 202...
The Meta deal lights up new questions about AMD's growth path and dilution risk. This guide breaks down what the 6 gi...
As Walmart names John Furner CEO, the retail giant leans on AI and a family-led leadership creed to reshape operation...
NVIDIA unveiled the Vera Rubin platform at GTC, pairing new Rubin GPUs with an 88-core Vera CPU and forecasting $1 tr...
Capital One’s stock sits near $184 after a wave of acquisitions and an earnings miss. Here’s what Wall Street expects...
Platform-scale brokerages are redefining how buyer leads are allocated and how loans are funded. The shift, powered b...
Take-Two is set to report Q4 results after market close, with GTA VI's looming launch shaping investor sentiment. Gui...
A senior U.S. defense official is pushing allies to back a quiet Taiwan stance, a move that could redefine regional s...
Broadcom posted a record AI-led quarter, while Qualcomm balanced handset softness with rising auto and licensing mome...
Investors eye AGNC for a high yield, but sustainability is key. This analysis breaks down how AGNC funds its dividend...